Paper Details

  1. Home
  2. Paper Details

Antiandrogen, vaccine and combination therapy in patients with nonmetastatic hormone refractory prostate cancer.

Author: ArlenPhilip M, BastianAnne, BeethamPatricia, DahutWilliam, GrosenbachDouglas W, GulleyJames L, LiebermanRonald, MarteJennifer, MorinSteve, SchlomJeffrey, SteinbergSeth M, ToddNushin, TsangKwong-Yok

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

This study examines different treatment strategies for prostate cancer patients who have already had hormone therapy but are showing signs of disease progression. The study compares the use of a vaccine, antiandrogen therapy, and sequential combinations of these treatments to determine their effectiveness, safety, and how long they prevent disease progression.
Paper Details　
Original Abstract of the Article :
There is no current standard treatment for patients with prostate cancer who have received hormonal therapy but have an increasing prostate specific antigen (PSA) without radiographic evidence of metastasis. This trial was designed to analyze toxicity, immunogenicity and time to treatment failure us...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1097/01.ju.0000165159.33772.5b

データ提供：米国国立医学図書館（NLM）

Fighting Prostate Cancer: A Multi-faceted Approach

In the vast desert of cancer research, scientists are constantly seeking new ways to combat this formidable foe. This research explores the potential of a multi-pronged approach, combining different therapies, to fight prostate cancer, a challenging condition that affects millions of men worldwide.

A Multi-pronged Attack on Prostate Cancer

The researchers, like skilled warriors strategizing a campaign in a vast and challenging desert, investigated the potential of combining antiandrogen therapy, vaccines, and other therapies to combat hormone-refractory prostate cancer. This study focused on the toxicity, immunogenicity, and time to treatment failure of these different therapies, both alone and in combination. It's like a multi-pronged attack, utilizing different weapons and strategies to overwhelm the enemy.

A Promising Path Towards Better Treatment

The findings of this study suggest that a multi-faceted approach could be a promising avenue for treating hormone-refractory prostate cancer. It's like finding a new oasis in the vast desert of cancer research, offering a more effective and personalized approach to fighting this disease. Further research is needed to fully optimize these therapies and understand their long-term benefits and risks, but the initial findings are encouraging.

Dr. Camel's Conclusion

This research delves into the potential of combining different therapies to fight prostate cancer, a promising development in the ongoing battle against this challenging disease. It's like finding a new weapon in the vast desert of cancer research, offering a more comprehensive and effective approach to treating this condition.
Date :
  1. Date Completed 2005-09-16
  2. Date Revised 2014-11-20
Further Info :

Pubmed ID

16006888

DOI: Digital Object Identifier

10.1097/01.ju.0000165159.33772.5b

Related Literature

Article Analysis
・Effective treatment of prostate cancer
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.